CyberKnife robotic radiosurgery is a new and exciting method of noninvasive surgery. This FDA approved technology can rid both cancerous and noncancerous tumors from anywhere in the body, with minimal recovery time after the procedure. More than 70,000 patients worldwide have been successfully treated with CyberKnife.
CyberKnife can treat head, neck, spine, lung, skull base, cranial, pancreatic, renal, prostate, skeletal and hepatic radiosurgeries. Before the actual procedure, the patient will go through a CT or MRI scan to view the tumor. Small metal markers called fiducials will be implanted on an outpatient basis to track the radiation from the procedure.
This procedure is performed on inoperable or complex tumors and lesions through beams of high dose radiation. Guidance cameras are utilized to view the tumor or lesion and a robotic arm precisely targets the radiation without affecting nearby tissues. This allows the patients to relax and breathe normally throughout the entire procedure.
Cyberknife is pain-free, and most treatment plans only require 1-5 visits, each ranging 30 -90 minutes. Cyberknife also results in less post-treatment complications such as infections and hemorrhages that are frequent in invasive surgeries. Patients commonly experience little to no recovery time immediately after the procedure, allowing them to go on with regular activities throughout the day. It is also available to patients who have reached conventional radiation therapy limits.
Patients of Somerset Urological Associates have this revolutionary treatment option available to them. The Cyberknife Robotic Radiosurgery is performed at Saint Peter’s University Hospital in New Brunswick, New Jersey.